Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
Open-market buys, last 90 days
$1,681,140
in 2 filings
Open-market sales, last 90 days
$425,829
in 1 filing, $426K under 10b5-1 plans

Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-12-11 AZAB MOHAMMAD Director Exercise or conversion · Stock Option (Right to Buy) +2,469 0
2015-11-24 HOLLER FRANK A Director Exercise or conversion +2,057 $5.22 $11K 176,864
2015-11-24 HOLLER FRANK A Director Shares withheld for taxes −995 $9.39 $9K 175,869
2015-11-24 HOLLER FRANK A Director Exercise or conversion · Stock Option (Right to Buy) −2,057 0
2015-11-04 PATOU GARY Director Exercise or conversion +3,497 $5.22 $18K 6,041
2015-11-04 PATOU GARY Director Shares withheld for taxes −1,955 $8.32 $16K 4,086
2015-11-04 PATOU GARY Director Exercise or conversion · Stock Option (Right to Buy) −3,497 0
2015-11-02 TARNOW MICHAEL M Director Exercise or conversion +5,041 $5.22 $26K 60,208
2015-11-02 TARNOW MICHAEL M Director Gift −5,041 55,167
2015-11-02 TARNOW MICHAEL M Director Exercise or conversion · Stock Option (Right to Buy) −5,041 0
2015-09-24 GOLDBERG Y. PAUL VP of Clinical Development Sale −12,000 $8.60 $103K 6,000
2015-09-23 GOLDBERG Y. PAUL VP of Clinical Development Sale −4,000 $9.02 $36K 18,000
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion +411 $5.22 $2K 6,514
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Shares withheld for taxes −198 $9.53 $2K 6,316
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion +2,057 $3.21 $7K 8,373
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Shares withheld for taxes −610 $9.53 $6K 7,763
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion +1,028 $3.77 $4K 8,791
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Shares withheld for taxes −305 $9.53 $3K 8,486
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Exercise or conversion +5,144 $3.07 $16K 13,630
2015-09-22 GOLDBERG Y. PAUL VP of Clinical Development Shares withheld for taxes −1,525 $9.53 $15K 12,105

Page 36 of 42 · 836 trades